Subsequently, the anti-cancer mechanism of lidocaine in ovarian cancer was explored, and it was found that lidocaine promoted iron ptosis through MiR-382-5p/SLC7A11 axis, thereby inhibiting the cell viability and proliferation of ovarian cancer cells, inducing apoptosis, and weakening invasion and migration ability (Sun D. et al., 2021). This evidence concerns the gene SLC7A11 and ovarian carcinoma.